Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
s5UpyfZ39hcL41Sr
